Evidence that the apoptotic actions of etoposide are independent of c- Jun/activating protein-1-mediated transregulation

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1384-1392

  Jarvis, W David ^a   Johnson, Charlene R ^a   Fornari, Frank A ^c   Park, Jong Sung ^d   Dent, Paul ^b   Grant, Steven ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Dominion   (United States)

^d MED HEM/ONC ^*

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CURCUMIN; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; SPHINGOSINE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CYTOTOXICITY; DNA DAMAGE; DNA DEGRADATION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CURCUMIN; ETOPOSIDE; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 0032768232     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Beck WT, Kim R and Chen M (1994) Novel actions of inhibitors of DNA topoisomerase II. Cancer Chem Pharm 34:S14-S18.
2. Bierhaus A, Zhang H, Quehenberger P, Luther T, Haase M, Muller M, Mademann M, Ziegler R and Nawroth PP (1997) The dietary pigment curcumin inhibits endothelial tissue factor gene expression and binding of AP-1 to DNA and activation of NFκB. Thromb Haemost Ostasis 77:772-782.
3. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K and Kolesnick RN (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82:405-414.
4. Brach MA, Herrmann F and Kufe DW (1992) Activation of the AP-1 transcription factor by 1-[β-D-arabinofuranosyl]cytosine in myeloid leukemia cells. Blood 79: 728-734.
5. Brown PH, Chen TK and Birrer MJ (1994) Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:791-797.
6. Eliot HE, Borner MM and Sinha BK (1995) Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL-60 cell line: Implications for etoposide resistance. Anticancer Res 15:729-733.
7. Filipski J, LeBlanc J, Yondale T, Sikorska M and Walker PR (1990) Periodicity of DNA folding in higher order chromatin structures. EMBO J 9:1319-1327.
8. Freemerman AJ, Turner AJ, Birrer MJ, Szabo E, Vallerie K and Grant S (1996) Role of c-Jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C. Mol Pharmacol 49:788-795.
9. Gajate C, Alonso MT, Schimmang T and Mollinedo F (1996) c-Fos is not essential for apoptosis. Biochem Biophys Res Commun 218:267-272.
10. Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J and Jarvis WD (1996) Effect of 1-[β-D-arabinofuranosyl]cytosine on apoptosis and differentiation in human monoblastic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM-67). Cell Growth Differ 7:603-613.
11. Gupta S, Campbell D, Derijard B and Davis RJ (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (Wash, DC) 267:389-393.
12. Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv Y and Rubin LL (1995) A c-Jun dominant-negative protects sympathetic neurons against programmed cell death. Neuron 14:927-939.
13. Ip YT and Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase. Curr Opin Cell Biol 10:205-219.
14. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA and Grant S (1994a) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 91:73-77.
15. Jarvis WD, Fornari FA, Browning JL, Gewirtz DA, Kolesnick RN and Grant S (1994b) Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem 269:31658-31692.
16. Jarvis WD, Fornari FA, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Auer KL, Dent P and Grant S (1997) Coordinate regulation of stress-activated protein kinase (SAPK) and mitogen-activated protein kinase (MAPK) cascades in the apoptotic actions of ceramide and sphingosine in human myeloid leukemia cells. Mol Pharmacol 52:935-947.
17. Jarvis WD, Fornari FA, Tombes RB, Erukulla RK, Bittman R, Schwartz GK, Dent P and Grant S (1998) Direct evidence for involvement of mitogen-activated protein kinase (MAPK), rather than stress-activated protein kinase (SAPK), in potentiation of 1-[β-D-arabinofuranosyl]cytosine-induced apoptosis by interruption of protein kinase C signaling. Mol Pharmacol 54:844-856.
18. Jarvis WD, Fornari FA, Traylor RS, Martin HA, Kramer LB, Erukulla RK, Bittman R and Grant S (1996) Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J Biol Chem 271:8275-8284.
19. Jarvis WD and Grant S (1998) The role of ceramide in the apoptotic response to antineoplastic agents. Curr Opin Oncol 10:552-559.
20. Kharbanda SM, Sherman MC and Kufe DW (1990) Transcriptional regulation of c-jun gene expression by 1-[β-D-arabinofuranosyl]cytosine in human myeloid leukemia cells. J Clin Invest 86:1517-1523.
21. Kyriakis JM, Bannerjee P, Nikkolaki E, Dai T, Rubin EA, Ahmad MF, Avruch J and Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun aminoterminal kinases. Nature 369:156-160.
22. Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351-566.
23. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska M (1993) Apoptotic death in epithelial cells: Cleavage of DNA into 300-kbp and 50-kbp fragments prior to, or in the absence of, internucleosomal fragmentation. EMBO J 12:3679-3684.
24. Ohta H, Yatomi Y, Sweeney EA, Hakomori S-I and Igarashi Y (1994) A possible role for sphingosine in induction of apoptosis by tumor necrosis factor in human neutrophils. FEBS Lett 355:267-270.
25. 2-terminal protein kinase pathway in the cellular response to chemotherapeutic drugs. J Biol Chem 271:30950-30955.
26. Pendurthi UR, Williams JT and Rao LV (1996) Inhibition of tissue factor gene expression by curcumin: Suppression of activation of transcription factors Egr-1, AP-1, and NFκB. Arterioscler Thromb Vase Biol 17:3406-3413.
27. Perez C, Vilaboa NE and Aller P (1994) Etoposide-induced differentiation of U937 promonocytic cells: AP1-dependent gene expression and protein kinase C activation. Cell Growth Differ 5:949-955.
28. Pommier Y, Fesen MR and Goldwasser F (1995) Topoisomerase II inhibitors: The epipodophyooltoxins, m-AMSA, and the ellipticine derivatives, in Cancer Chemotherapy: Principles & Practice (Chabner BA and Longo DL eds).
29. Pommier Y, Leteurtre F, Fesen MR, Fujimori A, Bertrand R, Solary E, Kohlagen G and Kohn KW (1994) Cellular determinants of sensitivity and resistance to DNA topoisomerase II inhibitors. Cancer Invest 12:530-542.
30. Ritke MK, Bergoltz VV, Allan WP and Yalowich JC (1994a) Increased c-Jun/AP-1 levels in etoposide-resistant human leukemia K562 cells. Biochem Pharmacol 48:525-533.
31. Ritke MK and Yalowich JC (1993) Altered gene expression in human leukemia K562 cells selected for resistance to etoposide. Biochem Pharmacol 46:2007-2020.
32. Ritke MK, Rusnack JM, Lazo JS, Allan WP, Dive C, Heer S and Yalowich JC (1994b) Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol Pharmacol 46:605-611.
33. Rubin E, Kharbanda S, Gunji H and Kufe DW (1991) Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide. Mol Pharmacol 39:697-701.
34. Saleem A, Datta R, Yuan Z-M, Kharbanda SM and Kufe DW (1995) Involvement of stress-activated protein kinase in the cellular response to 1-[β-D-arabinofuranosyl]cytosine and other DNA-damaging agents. Cell Growth Differ 6:1651-1658.
35. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM and Zon LI (1994) Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating the transcription factor c-Jun. Nature (Lond) 372:794-798.
36. Sawai H, Okazaki T, Yamamoto H, Okano H, Takeda Y, Tashima M, Sawada H, Okuma M, Ishikura H, Umehara H and Domae N (1995) Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 270: 27326-27331.
37. 2-terminal kinase-mediated activation of a ICE/CED-3-like protease during anticancer drug-induced apoptosis. J Biol Chem 272:4631-4636.
38. Strum JL, Small GW, Pauig SB and Daniel LW (1994) 1-[β-D-arabinofuranosyl]cytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 269:5493-15497.
39. Sundstrom C and Nilsson K (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int J Cancer 17:565-577.
40. Testolin L, Carson C, Wang Y, Walker PR, Armato U and Sikorska M (1997) Jun and JNK kinase are activated in thymocytes in response to VM-26 and radiation, but not glucocorticoids. Exp Cell Res 230:220-232.
41. Tewey KM, Chen GL, Nelson EM and Liu LF (1984) Intercalative anti-cancer drugs interfere with the breakage-reunion reaction of topoisomerase II. J Biol Chem 259:9182-9187.
42. Verheij M, Bose R, Lin X-H, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zons LI, Kyriakis JM, Haimovitz-Friedman A, Fuks ZY and Kolesnick RN (1996) Requirement for ceramide-initiated stress-activated protein kinase/c-Jun aminoterminal kinase (SAPK/JNK) signaling in stress-induced apoptosis. Nature (Lond) 380:75-79.
43. Widmann C, Gibson S and Johnson GL (1998) Caspase-dependent cleavage of signaling proteins during apoptosis: A turn-off mechanism anti-apoptotic signals. J Biol Chem 273:7141-7147.
44. Yamamoto H (1995) Interrelation of differentiation, proliferation, and apoptosis in cancer cells. J Osaka Dent Univ 29:51-60.
45. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR and Templeton DJ (1994) Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature (Lond) 872:798-800.